BACKGROUND: The outcome of patients with severe ischaemic left ventricular (LV) dysfunction is determined by the extent of myocardial viability and the presence of LV dyssynchrony. We aimed at assessing both parameters from the same imaging method, i.e. gated positron emission tomography (PET) F18-fluorodeoxyglucose (FDG) scans. METHODS: Phase analysis from Emory Cardiac Toolbox was applied on gated PET-FDG scans to assess histogram bandwidth and standard deviation (SD) as a measure of LV dyssynchrony in 30 heart failure patients (mean ejection fraction: 30.2% ± 13.8%) referred for the evaluation of myocardial viability. Cut-off values from single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) best predicting cardiac resynchronization therapy (CRT) response served as standard of reference (bandwidth < 135°; phase SD < 43°). Severe LV dyssynchrony was diagnosed if both SPECT-MPI values were above these limits. Intraclass correlation and clinical agreement in detection of severe LV dyssynchrony by PET vs SPECT were assessed. RESULTS: There was a significant correlation between PET-FDG and SPECT-MPI for bandwidth (r = 0.88, P < .001) and phase SD (r = 0.88, P < .001) resulting in an excellent clinical agreement between the two methods of 93%. CONCLUSIONS: Accurate LV dyssynchrony assessment by phase analysis of gated PET-FDG scans is feasible, allowing assessing myocardial viability and severe LV dyssynchrony in one scan.
BACKGROUND: The outcome of patients with severe ischaemic left ventricular (LV) dysfunction is determined by the extent of myocardial viability and the presence of LV dyssynchrony. We aimed at assessing both parameters from the same imaging method, i.e. gated positron emission tomography (PET) F18-fluorodeoxyglucose (FDG) scans. METHODS: Phase analysis from Emory Cardiac Toolbox was applied on gated PET-FDG scans to assess histogram bandwidth and standard deviation (SD) as a measure of LV dyssynchrony in 30 heart failurepatients (mean ejection fraction: 30.2% ± 13.8%) referred for the evaluation of myocardial viability. Cut-off values from single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) best predicting cardiac resynchronization therapy (CRT) response served as standard of reference (bandwidth < 135°; phase SD < 43°). Severe LV dyssynchrony was diagnosed if both SPECT-MPI values were above these limits. Intraclass correlation and clinical agreement in detection of severe LV dyssynchrony by PET vs SPECT were assessed. RESULTS: There was a significant correlation between PET-FDG and SPECT-MPI for bandwidth (r = 0.88, P < .001) and phase SD (r = 0.88, P < .001) resulting in an excellent clinical agreement between the two methods of 93%. CONCLUSIONS: Accurate LV dyssynchrony assessment by phase analysis of gated PET-FDG scans is feasible, allowing assessing myocardial viability and severe LV dyssynchrony in one scan.
Authors: Jeroen J Bax; Thomas H Marwick; Sander G Molhoek; Gabe B Bleeker; Lieselot van Erven; Eric Boersma; Paul Steendijk; Ernst E van der Wall; Martin J Schalij Journal: Am J Cardiol Date: 2003-11-15 Impact factor: 2.778
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Claudia Ypenburg; Martin J Schalij; Gabe B Bleeker; Paul Steendijk; Eric Boersma; Petra Dibbets-Schneider; Marcel P M Stokkel; Ernst E van der Wall; Jeroen J Bax Journal: Eur Heart J Date: 2006-11-22 Impact factor: 29.983
Authors: Martin Penicka; Petr Tousek; Bernard De Bruyne; William Wijns; Otto Lang; Juraj Madaric; Marc Vanderheyden; Jaroslav Tintera; Marek Malý; Petr Widimsky; Jozef Bartunek Journal: Eur Heart J Date: 2007-01-05 Impact factor: 29.983
Authors: Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko Journal: J Am Coll Cardiol Date: 2007-10-10 Impact factor: 24.094
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Martin Penicka; Jozef Bartunek; Otto Lang; Karel Medilek; Petr Tousek; Marc Vanderheyden; Bernard De Bruyne; Michaela Maruskova; Petr Widimsky Journal: J Am Coll Cardiol Date: 2007-09-17 Impact factor: 24.094
Authors: Maureen M Henneman; Ji Chen; Claudia Ypenburg; Petra Dibbets; Gabe B Bleeker; Eric Boersma; Marcel P Stokkel; Ernst E van der Wall; Ernest V Garcia; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2007-04-05 Impact factor: 24.094
Authors: Wael AlJaroudi; M Chadi Alraies; Venu Menon; Richard C Brunken; Manuel D Cerqueira; Wael A Jaber Journal: J Nucl Cardiol Date: 2012-06-13 Impact factor: 5.952
Authors: Sebastian Lehner; Christopher Uebleis; Franziska Schüßler; Alexander Haug; Stefan Kääb; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Heidi Estner; Marcus Hacker Journal: Eur J Nucl Med Mol Imaging Date: 2013-08-01 Impact factor: 9.236
Authors: Wael AlJaroudi; M Chadi Alraies; Frank DiFilippo; Richard C Brunken; Manuel D Cerqueira; Wael A Jaber Journal: Eur J Nucl Med Mol Imaging Date: 2012-01-05 Impact factor: 9.236